Uterine rupture during therapeutic abortion in the second trimester using mifepristone and prostaglandin.
Norman
J E
JE
University of Glasgow Department of Obstetrics and Gynaecology, Queen Mother's Hospital, Yorkhill, Glasgow, UK.
D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects*; D000032:Abortion, Therapeutic / Q000009:adverse effects*; D000527:Alprostadil / Q000009:adverse effects / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D014597:Uterine Rupture / Q000209:etiology*
D000020:Abortifacient Agents, Nonsteroidal; D015735:Mifepristone; C021182:gemeprost; D000527:Alprostadil